Trial Profile
Effect of Low-dose vs. High-dose Pitavastatin on In-stent Restenosis, Endothelial Function, Circulating microRNAs, and Cardiovascular Events in Patients With Coronary Artery Disease Requiring Stent Implantation: OCT and NIRS Comparison
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 Nov 2020
Price :
$35
*
At a glance
- Drugs Pitavastatin (Primary)
- Indications Acute coronary syndromes; Atherosclerosis
- Focus Pharmacodynamics
- Acronyms ELEVATE
- 08 Nov 2020 Status changed from active, no longer recruiting to completed.
- 24 Apr 2019 Planned End Date changed from 1 Dec 2017 to 1 Nov 2019.
- 16 Aug 2017 Planned End Date changed from 1 Aug 2017 to 1 Dec 2017.